EsPhALL2017/COGAALL1631: International phase III trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
Principal investigator: Jukka Kanerva
HUS Helsinki University Hospital, New Children’s hospital
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
